Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Stacy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|December 15, 2018
Glaucoma - Next Generation Therapeutics: Impossible to PossibleChristopher M Adams, Rebecca Stacy, Nalini Rangaswamy, et al.
Ocular Immunology and Inflammation|May 21, 2011
Optic nerve involvement with panuveitis in Sweet syndromeAnn-Marie Lobo, Rebecca Stacy, Dean Cestari, et al.
American Journal of Ophthalmology|May 27, 2018
A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or GlaucomaRebecca Stacy, Kenneth Huttner, Jen Watts, et al.
Investigative Ophthalmology & Visual Science|April 4, 2018
A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular DosingGanesh Prasanna, Luciana Ferrara, Christopher Adams, et al.
Investigative Ophthalmology & Visual Science|January 21, 2026
Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular EndotypeKangjia Lv, Jiale Peng, Hanying Wang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|December 15, 2018
Glaucoma - Next Generation Therapeutics: Impossible to PossibleChristopher M Adams, Rebecca Stacy, Nalini Rangaswamy, et al.
Ocular Immunology and Inflammation|May 21, 2011
Optic nerve involvement with panuveitis in Sweet syndromeAnn-Marie Lobo, Rebecca Stacy, Dean Cestari, et al.
American Journal of Ophthalmology|May 27, 2018
A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or GlaucomaRebecca Stacy, Kenneth Huttner, Jen Watts, et al.
Investigative Ophthalmology & Visual Science|April 4, 2018
A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular DosingGanesh Prasanna, Luciana Ferrara, Christopher Adams, et al.
Investigative Ophthalmology & Visual Science|January 21, 2026
Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular EndotypeKangjia Lv, Jiale Peng, Hanying Wang, et al.
Pageof 1